China (Mainland)
Finasteride CAS: 98319-26-7 CAS NO.98319-26-7
- FOB Price: USD: 1,300.00-1,300.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,
- Available Specifications:
99%(1-2)Kilogram
- Product Details
Keywords
- Finasteride
- 98319-26-7
- Finasteride supplier
Quick Details
- ProName: Finasteride CAS: 98319-26-7
- CasNo: 98319-26-7
- Molecular Formula: C9H15N5O
- Appearance: powder or crystal
- Application: Finasteride CAS: 98319-26-7
- DeliveryTime: within 1-2days
- PackAge: Aluminum Foil Bag or as your requirem...
- Port: tianjin
- ProductionCapacity: 1000 Metric Ton/Month
- Purity: 99%
- Storage: keep in dry place
- Transportation: as your requirement
- LimitNum: 1 Kilogram
- Grade: Industrial Grade
- MOQ: 1KG
Superiority
We do following terms :
1) Best quality
2) Many years experience in this field
3) Loyal customers in countries
4) Professional big supplier
5) Safe shipping
6) Various payment terms
Product Name: Finasteride
Specification: 99%
Cas No: 98319-26-7
Appearance: White powder
Molecular formula: C23H36N2O2
Molecular weight: 372.54g/mol
Finasteride is an antiandrogen which acts by inhibiting type II 5-alpha reductase.It is used as a treatment in
benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses. It is also indicated for use in combination with doxazosin therapy to reduce the risk for symptomatic progression of BPH. Additionally, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
Finasteride was approved initially in 1992, a treatment for prostate enlargement, but the sponsor had studied 1 mg of finasteride and demonstrated hair growth in male pattern hair loss. On December 22, 1997, the FDA approved finasteride to treat male pattern hair loss.
Details
Product Name: Finasteride
Specification: 99%
Cas No: 98319-26-7
Appearance: White powder
Molecular formula: C23H36N2O2
Molecular weight: 372.54g/mol
Finasteride is an antiandrogen which acts by inhibiting type II 5-alpha reductase.It is used as a treatment in
benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses. It is also indicated for use in combination with doxazosin therapy to reduce the risk for symptomatic progression of BPH. Additionally, it is registered in many countries for androgenetic alopecia (male-pattern baldness).
Finasteride was approved initially in 1992, a treatment for prostate enlargement, but the sponsor had studied 1 mg of finasteride and demonstrated hair growth in male pattern hair loss. On December 22, 1997, the FDA approved finasteride to treat male pattern hair loss.
| Products | cas |
| RU58841 | 154992-24-2 |
| Setipiprant | 866460-33-5 |
| CB-03-01 | 19608-29-8 |
| Minoxidil | 38304-91-5 |
| Finasteride | 98319-26-7 |
| Dutasteride | 164656-23-9 |
| Orlistat | 96829-58-2 |
Packaging Details:
25kgs packaging Fiber drum outside and plastic bag inside 1-25kgs packaging aluminium bag outside and double plastic bag inside
Delivery Detail: within 3 days when get the payment.
Shipping :
We have Professional shipping agent, based on customers ' demand for transport
By express :FEDEX,DHL,EMS ,UPS,TNT ect.
By SEA and By AIR
